114 related articles for article (PubMed ID: 7064949)
1. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
Hendricks SA; Lippe BM; Kaplan SA; Lavin N; Mayes DM
Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
[TBL] [Abstract][Full Text] [Related]
2. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
Keenan BS; McNeel R; Barrett GN; Holcombe JH; Kirkland RT; Clayton GW
J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
[No Abstract] [Full Text] [Related]
3. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
Lippe BM; LaFranchi SH; Lavin N; Parlow A; Coyotupa J; Kaplan SA
J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
[No Abstract] [Full Text] [Related]
4. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
Lee PA; Urban MD; Gutai JP; Migeon CJ
Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
[TBL] [Abstract][Full Text] [Related]
5. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
Frisch H; Parth K; Schober E; Swoboda W
Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
[TBL] [Abstract][Full Text] [Related]
6. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.
Hughes IA; Winter JS
J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027
[TBL] [Abstract][Full Text] [Related]
7. Management of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value.
Bailey CC; Komrower GM; Palmer M
Arch Dis Child; 1978 Feb; 53(2):132-5. PubMed ID: 646414
[TBL] [Abstract][Full Text] [Related]
8. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
[TBL] [Abstract][Full Text] [Related]
9. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
Hansen JW; Loriaux DL
Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
[TBL] [Abstract][Full Text] [Related]
10. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
Bailey CC; Komrower GM
Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
[No Abstract] [Full Text] [Related]
11. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
Golden MP; Lippe BM; Kaplan SA; Lavin N; Slavin J
Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950
[TBL] [Abstract][Full Text] [Related]
12. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
McKenna TJ; Jennings AS; Liddle GW; Burr IM
J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
[TBL] [Abstract][Full Text] [Related]
13. Congenital virilizing adrenal hyperplasia without acceleration of growth or bone maturation.
Aceto T; MacGILLIVRAY MH; Caprano VJ; Munschauer RW; Raiti S
JAMA; 1966 Dec; 198(13):1341-3. PubMed ID: 6012557
[No Abstract] [Full Text] [Related]
14. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
Cattani A; Mahaha D; Michaud P; Rodríguez JA; López JM; García H; Foradori A; Velásquez CG
Rev Chil Pediatr; 1984; 55(6):374-9. PubMed ID: 6536989
[No Abstract] [Full Text] [Related]
15. The use of plasma androstenedione in monitoring therapy of patients with congenital adrenal hyperplasia.
Cavallo A; Corn C; Bryan GT; Meyer WJ
J Pediatr; 1979 Jul; 95(1):33-7. PubMed ID: 480011
[TBL] [Abstract][Full Text] [Related]
16. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
Hughes IA; Winter JS
J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
[TBL] [Abstract][Full Text] [Related]
17. Urinary steroids in fifteen cases of congenital virilizing adrenal hyperplasia.
Mizutani S; Kusunoki T; Matsumoto K; Seki T
Endocrinol Jpn; 1967 Jun; 14(2):148-57. PubMed ID: 6072545
[No Abstract] [Full Text] [Related]
18. Gas-liquid chromatography of underivatized steroids: simultaneous determination of urinary 17-ketosteroids, pregnanediol, pregnanetriol, and pregnanetriolone.
Sanghvi A; Wight C; Serenko A; Balachandran R
Clin Chim Acta; 1974 Oct; 56(1):49-57. PubMed ID: 4278796
[No Abstract] [Full Text] [Related]
19. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia.
Peterson RE; Imperato-McGinley J; Gautier T; Shackleton C
N Engl J Med; 1985 Nov; 313(19):1182-91. PubMed ID: 2932643
[TBL] [Abstract][Full Text] [Related]
20. [A contribution to the therapy of the congenital adrenal hyperplasia (author's transl)].
Gleispach H
Wien Klin Wochenschr; 1974 Sep; 86(17):508-11. PubMed ID: 4408420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
